More Girls Admitted With Pediatric Multiple Sclerosis
For pediatric patients with multiple sclerosis, there are more admissions among girls and among white children.
Multiple Sclerosis
First Generic Versions of Fingolimod Gain FDA Approval
The FDA has approved the first generic versions of fingolimod for the treatment of relapsing forms of multiple sclerosis in adults.
Increased Disability for Patients With Multiple Sclerosis and Comorbid Depression
The risk for disability worsening is increased for individuals with multiple sclerosis (MS) and comorbid depression.
Early Escalation to Highly Effective Drugs May Reduce Cognitive Impairment in Pediatric Multiple Sclerosis
Early initiation of highly effective escalation therapies in pediatric patients with MS is associated with reduced cognitive impairment and may prevent cognitive decline.
Many Multiple Sclerosis Patients Considering Stem Cell Transplant
Many multiple sclerosis (MS) patients are considering autologous hematopoietic stem cell transplantation (aHSCT) as a treatment option.
Cortical Atrophy and Cognitive Decline Accelerated in Stable and Progressive Multiple Sclerosis
Cortical atrophy and cognitive decline accelerate together during the course of multiple sclerosis.
Diroximel Fumarate Approved for Relapsing Forms of Multiple Sclerosis
Vumerity (diroximel fumarate; Biogen) has been approved for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.
Patients With Multiple Sclerosis Experience a Wearing-Off Effect During Natalizumab Treatment
More than half of patients with multiple sclerosis experienced a wearing-off effect during treatment with natalizumab.
Updated Algorithm Improves Specificity of UTI Detection in Patients With Relapsing Multiple Sclerosis
With an improved specificity, an updated algorithm for the detection of UTIs in patients with relapsing MS addresses previous issues concerning the unnecessary prescription of antibiotics, whilst improving accuracy and maintaining safety.
Retinal Nerve Fiber Loss Linked to Disability in Multiple Sclerosis
Reduction in peripapillary retinal nerve fiber layer (pRNFL) thickness is significantly associated with physical and cognitive disability in patients with multiple sclerosis.
Next post in Multiple Sclerosis
